Lv3
270 积分 2026-01-19 加入
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials
2天前
已完结
Commonalities Between pDCs and B Cells
4天前
求助中
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
12天前
已完结
Positive results for obinutuzumab in SLE phase III trial
13天前
已完结
Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions
16天前
已完结
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial
16天前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
16天前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
16天前
已完结
Discovery of GS-2278, a Potent and Selective LPAR1 Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis
19天前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
22天前
已完结
皖公网安备34019202002308
